Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (2) Costanza, Mariantonia Dr. (1) Daniel, Peter Prof. Dr. (1) Diecke, Sebastian Dr. (1) Fritsche, Raphaela Dr. (1) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Kastelic, Nicolai (1) Kempa, Stefan Dr. (7) Kirchner, Marieluise Dr. (2) Kühn, Ralf Dr. (1) Landthaler, Markus Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Mastrobuoni, Guido Dr. (2) Mathas, Stephan Dr. (5) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (8) Spuler, Simone Prof. (1) Uyar, Bora Dr. (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (3) (-) Janz, Martin Dr. (5) (-) Lusatis, Simone (1) (-) Willnow, Thomas Prof. Dr. (1) 1999 (1) 2000 (1) 2002 (1) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (3) 2014 (2) 2015 (2) 2016 (2) 2017 (3) (-) 2018 (3) 2020 (4) 2021 (3) 2022 (4) 2023 (6) 2024 (1) Bioinformatics and Omics Data Science (1) (-) Biology of Malignant Lymphomas (5) Developmental Biology / Signal Transduction (2) Genetics and Genomics of Cardiovascular Diseases (1) Genome Engineering & Disease Models (1) Integrative Vascular Biology (1) Molecular Biology of Peptide Hormones (1) Molecular Cardiovascular Research (15) Molecular Physiology of Somatic Sensation (3) Pluripotent Stem Cells (1) (-) Proteome Dynamics (2) (-) Proteomics and Metabolomics (1) Synaptic Transmission and Plasticity (1) Systems Biology of Gene Regulatory Elements (2) Transgenics (1) 7 Results: Active Filter: Janz, Martin Dr.Lusatis, SimoneWillnow, Thomas Prof. Dr.Biology of Malignant LymphomasProteome DynamicsProteomics and Metabolomics20062018 Sort: Result score Newest to oldest Oldest to newest March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken September 01, 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas May 10, 2018 / Genes Dev Maf links Neuregulin1 signaling to cholesterol synthesis in myelinating Schwann cells M. Kim H. Wende J. Walcher J. Kühnemund C. Cheret S. Kempa E. McShane M. Selbach G.R. Lewin C. Birchmeier September 20, 2018 / Cell Mutations in disordered regions can cause disease by creating dileucine motifs K. Meyer M. Kirchner B. Uyar J.Y. Cheng G. Russo L.R. Hernandez-Miranda A. Szymborska H. Zauber I.M. Rudolph T.E. Willnow A. Akalin V. Haucke H. Gerhardt C. Birchmeier R. Kühn M. Krauss S. Diecke J.M. Pascual M. Selbach May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
September 01, 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
May 10, 2018 / Genes Dev Maf links Neuregulin1 signaling to cholesterol synthesis in myelinating Schwann cells M. Kim H. Wende J. Walcher J. Kühnemund C. Cheret S. Kempa E. McShane M. Selbach G.R. Lewin C. Birchmeier
September 20, 2018 / Cell Mutations in disordered regions can cause disease by creating dileucine motifs K. Meyer M. Kirchner B. Uyar J.Y. Cheng G. Russo L.R. Hernandez-Miranda A. Szymborska H. Zauber I.M. Rudolph T.E. Willnow A. Akalin V. Haucke H. Gerhardt C. Birchmeier R. Kühn M. Krauss S. Diecke J.M. Pascual M. Selbach
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas